Income Taxes - Net Deferred Tax Assets - Valuation Allowance (Details) - USD ($) $ in Millions	12 Months Ended
Dec. 31, 2025	Dec. 31, 2024
Valuation Allowance
Increase (decrease) in the valuation allowance	$ 74.8	$ 26.8
Pulmokine
Valuation Allowance
Increase (decrease) in the valuation allowance		$ (5.7)

Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-2

Name:	us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration